1. Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice
- Author
-
Vinayak Rayannavar, Terrell Holloway, José L. Moreno, Javier González-Maeso, and Stuart C. Sealfon
- Subjects
Male ,Hallucinogen ,Ketanserin ,medicine.drug_class ,Mescaline ,Pharmacology ,Receptors, Metabotropic Glutamate ,Article ,Mice ,Radioligand Assay ,medicine ,Animals ,Receptor, Serotonin, 5-HT2A ,Amino Acids ,Early Growth Response Protein 2 ,5-HT receptor ,Early Growth Response Protein 1 ,Lysergic acid diethylamide ,Mice, Knockout ,Chemistry ,General Neuroscience ,Somatosensory Cortex ,Receptor antagonist ,Lysergic Acid Diethylamide ,Metabotropic receptor ,Xanthenes ,Hallucinogens ,Serotonin ,Stereotyped Behavior ,Drug Antagonism ,Proto-Oncogene Proteins c-fos ,medicine.drug - Abstract
Hallucinogenic drugs, such as lysergic acid diethylamide (LSD), mescaline and psilocybin, alter perception and cognitive processes. All hallucinogenic drugs have in common a high affinity for the serotonin 5-HT(2A) receptor. Metabotropic glutamate 2/3 (mGlu2/3) receptor ligands show efficacy in modulating the cellular and behavioral responses induced by hallucinogenic drugs. Here, we explored the effect of chronic treatment with the mGlu2/3 receptor antagonist 2S-2-amino-2-(1S,2S-2-carboxycyclopropan-1-yl)-3-(xanth-9-yl)-propionic acid (LY341495) on the hallucinogenic-like effects induced by LSD (0.24mg/kg). Mice were chronically (21 days) treated with LY341495 (1.5mg/kg), or vehicle, and experiments were carried out one day after the last injection. Chronic treatment with LY341495 down-regulated [(3)H]ketanserin binding in somatosensory cortex of wild-type, but not mGlu2 knockout (KO), mice. Head-twitch behavior, and expression of c-fos, egr-1 and egr-2, which are responses induced by hallucinogenic 5-HT(2A) agonists, were found to be significantly decreased by chronic treatment with LY341495. These findings suggest that repeated blockade of the mGlu2 receptor by LY341495 results in reduced 5-HT(2A) receptor-dependent hallucinogenic effects of LSD.
- Published
- 2013
- Full Text
- View/download PDF